Application 211710
- Type
- NDA
- Sponsor
- BAYER HEALTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VITRAKVI | LAROTRECTINIB SULFATE | SOLUTION;ORAL | EQ 20MG BASE/ML | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N211710-001 | VITRAKVI | LAROTRECTINIB SULFATE | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N211710-001 | 10005783 | 2029-10-21 | U-2472 | 2018-12-20 | |
| N211710-001 | 10047097 | 2029-10-21 | U-2474 | 2018-12-20 | |
| N211710-001 | 10774085 | 2029-10-21 | U-2470 | 2020-10-14 | |
| N211710-001 | 8865698 | 2029-10-21 | U-2469 | 2018-12-20 | |
| N211710-001 | 9127013 | 2029-10-21 | Drug substance, Drug product | 2018-12-20 | |
| N211710-001 | 9447104 | 2029-10-21 | U-2470 | 2018-12-20 | |
| N211710-001 | 9676783 | 2029-10-21 | U-2469 | 2018-12-20 | |
| N211710-001 | 8513263 | 2029-12-23 | Drug substance, Drug product | 2018-12-20 | |
| N211710-001 | 10172861 | 2035-11-16 | Drug substance | 2019-06-13 | |
| N211710-001 | 9782414 | 2035-11-16 | U-2471 | 2018-12-20 | |
| N211710-001 | 10799505 | 2036-08-15 | Drug substance | 2021-04-01 | |
| N211710-001 | 10045991 | 2037-04-04 | U-2473 | 2018-12-20 | |
| N211710-001 | 10137127 | 2037-04-04 | Drug product | 2018-12-20 | |
| N211710-001 | 10668072 | 2037-04-04 | Drug product | 2020-09-17 | |
| N211710-001 | 11191766 | 2037-04-04 | U-2471 | 2023-03-10 | |
| N211710-001 | 11484535 | 2037-04-04 | U-2470 | 2023-03-10 | |
| N211710-001 | 11337967 | 2037-05-16 | U-4123 | 2025-02-19 | |
| N211710-001 | 11974998 | 2037-05-16 | U-4124 | 2025-02-19 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N211710-001 | VITRAKVI | EQ 20MG BASE/ML | SOLUTION / ORAL | RLD, RS | 2018-11-26 | e64feba35796… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 10005783 | 2029-10-21 | U-2472 | 2018-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 10047097 | 2029-10-21 | U-2474 | 2018-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 10774085 | 2029-10-21 | U-2470 | 2020-10-14 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 8865698 | 2029-10-21 | U-2469 | 2018-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 9127013 | 2029-10-21 | Drug substance, Drug product | 2018-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 9447104 | 2029-10-21 | U-2470 | 2018-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 9676783 | 2029-10-21 | U-2469 | 2018-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 8513263 | 2029-12-23 | Drug substance, Drug product | 2018-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 10172861 | 2035-11-16 | Drug substance | 2019-06-13 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 9782414 | 2035-11-16 | U-2471 | 2018-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 10799505 | 2036-08-15 | Drug substance | 2021-04-01 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 10045991 | 2037-04-04 | U-2473 | 2018-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 10137127 | 2037-04-04 | Drug product | 2018-12-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 10668072 | 2037-04-04 | Drug product | 2020-09-17 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 11191766 | 2037-04-04 | U-2471 | 2023-03-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 11484535 | 2037-04-04 | U-2470 | 2023-03-10 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 11337967 | 2037-05-16 | U-4123 | 2025-02-19 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N211710-001 | 11974998 | 2037-05-16 | U-4124 | 2025-02-19 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 10005783 | 2029-10-21 | U-2472 | 2018-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 10047097 | 2029-10-21 | U-2474 | 2018-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 10774085 | 2029-10-21 | U-2470 | 2020-10-14 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 8865698 | 2029-10-21 | U-2469 | 2018-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 9127013 | 2029-10-21 | Drug substance, Drug product | 2018-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 9447104 | 2029-10-21 | U-2470 | 2018-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 9676783 | 2029-10-21 | U-2469 | 2018-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 8513263 | 2029-12-23 | Drug substance, Drug product | 2018-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 10172861 | 2035-11-16 | Drug substance | 2019-06-13 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 9782414 | 2035-11-16 | U-2471 | 2018-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 10799505 | 2036-08-15 | Drug substance | 2021-04-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 10045991 | 2037-04-04 | U-2473 | 2018-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 10137127 | 2037-04-04 | Drug product | 2018-12-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 10668072 | 2037-04-04 | Drug product | 2020-09-17 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 11191766 | 2037-04-04 | U-2471 | 2023-03-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 11484535 | 2037-04-04 | U-2470 | 2023-03-10 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 11337967 | 2037-05-16 | U-4123 | 2025-02-19 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N211710-001 | 11974998 | 2037-05-16 | U-4124 | 2025-02-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211710-001 | 10005783 | 2029-10-21 | U-2472 | 2018-12-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211710-001 | 10047097 | 2029-10-21 | U-2474 | 2018-12-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211710-001 | 10774085 | 2029-10-21 | U-2470 | 2020-10-14 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211710-001 | 8865698 | 2029-10-21 | U-2469 | 2018-12-20 | 31067a03dcf5… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211710-001 | ODE-215 | 2025-11-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211710-001 | ODE-220 | 2025-11-26 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N211710-001 | ODE-221 | 2025-11-26 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N211710-001 | ODE-215 | 2025-11-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N211710-001 | ODE-220 | 2025-11-26 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N211710-001 | ODE-221 | 2025-11-26 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211710-001 | ODE-215 | 2025-11-26 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211710-001 | ODE-220 | 2025-11-26 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N211710-001 | ODE-221 | 2025-11-26 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211710-001 | ODE-215 | 2025-11-26 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211710-001 | ODE-220 | 2025-11-26 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N211710-001 | ODE-221 | 2025-11-26 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211710-001 | ODE-215 | 2025-11-26 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211710-001 | ODE-220 | 2025-11-26 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N211710-001 | ODE-221 | 2025-11-26 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211710-001 | ODE-215 | 2025-11-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211710-001 | ODE-220 | 2025-11-26 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N211710-001 | ODE-221 | 2025-11-26 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211710-001 | ODE-215 | 2025-11-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211710-001 | ODE-220 | 2025-11-26 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N211710-001 | ODE-221 | 2025-11-26 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211710-001 | ODE-215 | 2025-11-26 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211710-001 | ODE-220 | 2025-11-26 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N211710-001 | ODE-221 | 2025-11-26 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | N211710-001 | ODE-215 | 2025-11-26 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N211710-001 | ODE-220 | 2025-11-26 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | N211710-001 | ODE-221 | 2025-11-26 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N211710-001 | ODE-215 | 2025-11-26 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N211710-001 | ODE-220 | 2025-11-26 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N211710-001 | ODE-221 | 2025-11-26 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N211710-001 | ODE-215 | 2025-11-26 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N211710-001 | ODE-220 | 2025-11-26 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N211710-001 | ODE-221 | 2025-11-26 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N211710-001 | ODE-215 | 2025-11-26 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N211710-001 | ODE-220 | 2025-11-26 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N211710-001 | ODE-221 | 2025-11-26 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | N211710-001 | ODE-215 | 2025-11-26 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N211710-001 | ODE-220 | 2025-11-26 | 8072bd15b7f6… |
| 2024-05-31 18:47 UTC | 2024-05 | N211710-001 | ODE-221 | 2025-11-26 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N211710-001 | NCE | 2023-11-26 | 5c6f7cd8ea54… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | 0c8ca614-58b2-4aa4-83d3-0387a8f782fd | 2026-05-22 | Warnings, Adverse reactions | 211710 NDA211710 50419-392 50419-393 |
| VITRAKVI | LAROTRECTINIB | Loxo Oncology, Inc. | 9525f887-a055-4e33-8e92-898d42828cd1 | 2018-12-05 | Warnings, Adverse reactions | 211710 NDA211710 71777-392 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 50419-392 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-392 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-392 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-392 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-392 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-392 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-392 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 50419-393 | VITRAKVI | LAROTRECTINIB | Bayer HealthCare Pharmaceuticals Inc. | NDA | Current |
| 71777-392 | VITRAKVI | LAROTRECTINIB | Loxo Oncology, Inc. | NDA | Current |
| 71777-392 | VITRAKVI | LAROTRECTINIB | Loxo Oncology, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 82013 | SUPPL | 2025-04-25 |
| 81925 | SUPPL | 2025-04-16 |
| 76370 | SUPPL | 2023-11-06 |
| 76369 | SUPPL | 2023-11-06 |
| 72728 | SUPPL | 2022-11-28 |
| 72702 | SUPPL | 2022-11-25 |
| 66918 | SUPPL | 2021-03-30 |
| 66899 | SUPPL | 2021-03-29 |
| 66887 | SUPPL | 2021-03-26 |
| 66885 | SUPPL | 2021-03-26 |
| 56772 | ORIG | 2018-12-18 |
| 56702 | ORIG | 2018-12-11 |
| 56562 | ORIG | 2018-11-26 |